Takeda Pharmaceutical Company Ltd
🇯🇵Japan
- Country
- 🇯🇵Japan
- Ownership
- -
- Established
- 1925-01-01
- Employees
- -
- Market Cap
- $47.5B
- Website
- http://www.takeda.co.jp/
Efficacy and Tolerability of Intranasal Fentanyl Spray for the Treatment of Breakthrough Pain in Cancer Patients Older Than 18 Years
- First Posted Date
- 2009-10-14
- Last Posted Date
- 2012-09-27
- Lead Sponsor
- Takeda
- Target Recruit Count
- 131
- Registration Number
- NCT00994760
- Locations
- 🇩🇪
Nycomed Deutschland GmbH, Zwönitz, Germany
Norwalk Vaccine Study
Phase 1
Completed
- Conditions
- Acute GastroenteritisNorwalk Virus Infection
- Interventions
- Biological: Norwalk VLP vaccineBiological: mannitol and sucroseBiological: Norwalk virus
- First Posted Date
- 2009-09-09
- Last Posted Date
- 2017-08-08
- Lead Sponsor
- Takeda
- Target Recruit Count
- 98
- Registration Number
- NCT00973284
- Locations
- 🇺🇸
Cincinnati Childrens Hospital Medical Center, Cincinnati, Ohio, United States
🇺🇸SNBL, Baltimore, Maryland, United States
🇺🇸Baylor College of Medicine, Houston, Texas, United States
Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome
Phase 3
Completed
- Conditions
- Diabetes Mellitus, Type 2Acute Coronary Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2009-08-31
- Last Posted Date
- 2014-05-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 5380
- Registration Number
- NCT00968708
Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus
- First Posted Date
- 2009-08-12
- Last Posted Date
- 2015-01-29
- Lead Sponsor
- Takeda
- Target Recruit Count
- 46
- Registration Number
- NCT00957268
Pharmacokinetics and Pharmacodynamics of TAK-875 in Subjects With Type 2 Diabetes
- First Posted Date
- 2009-07-30
- Last Posted Date
- 2010-06-11
- Lead Sponsor
- Takeda
- Target Recruit Count
- 60
- Registration Number
- NCT00949091
A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.
Phase 1
Completed
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2009-07-20
- Last Posted Date
- 2012-02-03
- Lead Sponsor
- Takeda
- Target Recruit Count
- 160
- Registration Number
- NCT00942175
Efficacy and Safety of Ramelteon on Chronic Insomnia
Phase 2
Completed
- Conditions
- Chronic Insomnia
- Interventions
- First Posted Date
- 2009-06-05
- Last Posted Date
- 2010-06-02
- Lead Sponsor
- Takeda
- Target Recruit Count
- 66
- Registration Number
- NCT00915135
Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults
- First Posted Date
- 2009-06-05
- Last Posted Date
- 2012-04-04
- Lead Sponsor
- Takeda
- Target Recruit Count
- 56
- Registration Number
- NCT00914862
Case Control Study of Pharmacogenomic Factors Associated With Hepatocellular Injury Following Exposure to Lapaquistat Acetate
Completed
- Conditions
- Toxicity
- Interventions
- Other: Pharmacogenomic whole blood sampling
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 66
- Registration Number
- NCT00890448
Safety of Lapaquistat Acetate in Subjects With Hypercholesterolemia
Phase 3
Completed
- Conditions
- Hypercholesterolemia
- Interventions
- First Posted Date
- 2009-03-24
- Last Posted Date
- 2012-05-24
- Lead Sponsor
- Takeda
- Target Recruit Count
- 574
- Registration Number
- NCT00868127
© Copyright 2025. All Rights Reserved by MedPath